[1] von Tappeiner H. Ueber die Wirkung fluorescirender Substanzen auf Fermente und Toxine[J]. Berichte Der Deutschen Chemischen Gesellschaft, 36, 3035-3038(1903).

[2] Chen J, Keltner L, Christophersen J et al. New technology for deep light distribution in tissue for phototherapy[J]. Cancer Journal, 8, 154-163(2002).

[3] Agostinis P, Berg K, Cengel K A et al[J]. Photodynamic therapy of cancer: an update, 61, 250-281(2011).

[4] Chen W L, Wang Z H, Tian M Y et al. Integration of TADF photosensitizer as “electron pump” and BSA as “electron reservoir” for boosting type I photodynamic therapy[J]. Journal of the American Chemical Society, 145, 8130-8140(2023).

[5] Kwiatkowski S, Knap B, Przystupski D et al. Photodynamic therapy: mechanisms, photosensitizers and combinations[J]. Biomedicine & Pharmacotherapy, 106, 1098-1107(2018).

[6] Rajora M A, Lou J W H, Zheng G. Advancing porphyrin’s biomedical utility via supramolecular chemistry[J]. Chemical Society Reviews, 46, 6433-6469(2017).

[7] Zhang L, Jiang J Q. Research progress of porphyrin photosensitizers[J]. Yunnan Chemical Technology, 45, 1-6(2018).

[8] Lipson R L, Baldes E J, Olsen A M. The use of a derivative of hematoporhyrin in tumor detection[J]. Journal of the National Cancer Institute, 26, 1-11(1961).

[9] Lipson R L, Baldes E J, Olsen A M. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease[J]. The Journal of Thoracic and Cardiovascular Surgery, 42, 623-629(1961).

[10] Kelly J F, Snell M E. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder[J]. The Journal of Urology, 115, 150-151(1976).

[11] Dougherty T J, Kaufman J E, Goldfarb A et al. Photoradiation therapy for the treatment of malignant tumors[J]. Cancer Research, 38, 2628-2635(1978).

[12] Balchum O J, Doiron D R, Huth G C. Photoradiation therapy of endobronchial lung cancers employing the photodynamic action of hematoporphyrin derivative[J]. Lasers in Surgery and Medicine, 4, 13-30(1984).

[13] Hayata Y, Kato H, Konaka C et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer[J]. Chest, 81, 269-277(1982).

[14] McCaughan J S, Jr, Hicks W, Laufman L et al. Palliation of esophageal malignancy with photoradiation therapy[J]. Cancer, 54, 2905-2910(1984).

[15] Han F L, Wu B Q, Xiong J et al. Application of hematoporphyrin derivatives (HPD) in laser diagnosis and treatment of malignant tumors[J]. Applied Laser, 16, 93-94(1996).

[16] Dougherty T J, Potter W R, Weishaupt K R. The structure of the active component of hematoporphyrin derivative[J]. Progress in Clinical and Biological Research, 170, 301-314(1984).

[17] Dougherty T J. Hematoporphyrin as a photosensitizer of tumors[J]. Photochemistry and Photobiology, 38, 377-379(1983).

[18] Dougherty T J, Cooper M T, Mang T S. Cutaneous phototoxic occurrences in patients receiving Photofrin®[J]. Lasers in Surgery and Medicine, 10, 485-488(1990).

[19] Dolmans D E J G J, Fukumura D, Jain R K. Photodynamic therapy for cancer[J]. Nature Reviews Cancer, 3, 380-387(2003).

[20] Renno R Z, Miller J W. Photosensitizer delivery for photodynamic therapy of choroidal neovascularization[J]. Advanced Drug Delivery Reviews, 52, 63-78(2001).

[21] Keam S J, Scott L J, Curran M P. Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation[J]. Drugs, 63, 2521-2554(2003).

[22] Battaglia Parodi M, La Spina C, Berchicci L et al. Photosensitizers and photodynamic therapy: verteporfin[J]. Developments in Ophthalmology, 55, 330-336(2016).

[23] Yu L, Li X Y. Advances in the second generation of photosensitizer hematoporphyrin monomethyl ether and its clinical applications[J]. Biomedical Engineering and Clinical Medicine, 9, 365-368(2005).

[24] Gu Y, Li J H, Wang K et al. Preliminary clinical observation of HMME in PDT for PWS[J]. Chinese Journal of Laser Medicine & Surgery, 5, 17-20(1996).

[25] Jiang J, Zou J, Chu E S M et al. Research progress of 5-aminolevulinic acid and its esters in photodynamic diagnosis and therapy[J]. Acta Laser Biology Sinica, 28, 289-295(2019).

[26] Stringasci M D, Ciol H, Romano R A et al. MAL-associated methyl nicotinate for topical PDT improvement[J]. Journal of Photochemistry and Photobiology B, 213, 112071(2020).

[27] Fan L L, Yin R, Lan T et al. Photodynamic therapy for rosacea in Chinese patients[J]. Photodiagnosis and Photodynamic Therapy, 24, 82-87(2018).

[28] Morton C A. Methyl aminolevulinate (Metvix) photodynamic therapy-practical pearls[J]. The Journal of Dermatological Treatment, 14, 23-26(2003).

[29] Grosjean P, Savary J F, Wagnières G et al. Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers[J]. Lasers in Medical Science, 11, 227-235(1996).

[30] Wang S, Bromley E, Xu L et al. Talaporfin sodium[J]. Expert Opinion on Pharmacotherapy, 11, 133-140(2010).

[31] Liu M, Li C H. Recent advances in activatable organic photosensitizers for specific photodynamic therapy[J]. ChemPlusChem, 85, 948-957(2020).

[32] Jiang Z, Shao J W, Yang T T et al. Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy[J]. Journal of Pharmaceutical and Biomedical Analysis, 87, 98-104(2014).

[33] Cognetti D M, Johnson J M, Curry J M et al. Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma[J]. Head & Neck, 43, 3875-3887(2021).

[34] Chen R J, Niu Y H, Chen T L et al. Hybrid registration method of narrow-band blood vessel image for vascular targeted photodynamic therapy[J]. Laser & Optoelectronics Progress, 59, 0617020(2022).

[35] Azzouzi A R, Barret E, Bennet J et al. TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer[J]. World Journal of Urology, 33, 945-953(2015).

[36] Min X Y, Cao N, Yan Y J et al. Research progress in new photodynamic therapy with padeliporfin[J]. Progress in Pharmaceutical Sciences, 43, 231-237(2019).

[37] Zheng X, Cui X G, Yu H D et al. Development of a quantitative method for four photocyanine isomers using differential ion mobility and tandem mass spectrometry and its application in a preliminary pharmacokinetics investigation[J]. Journal of Chromatography A, 1577, 109-119(2018).

[38] Wu J J, Zhang J, Xia C Y et al. Hypericin: a natural anthraquinone as promising therapeutic agent[J]. Phytomedicine, 111, 154654(2023).

[39] Karges J. Clinical development of metal complexes as photosensitizers for photodynamic therapy of cancer[J]. Angewandte Chemie (International Ed. in English), 61, e202112236(2022).

[40] Zhu B, Li S X, Zhang H et al. Advance on anti-tumor activities of sinoporphyrin sodium[J]. Academic Journal of Second Military Medical University, 39, 1259-1264(2018).

[41] Nava H R, Allamaneni S S, Dougherty T J et al. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett’s esophagus[J]. Lasers in Surgery and Medicine, 43, 705-712(2011).

[42] Arnaut L G, Pereira M M, Dąbrowski J M et al. Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers[J]. Chemistry, 20, 5346-5357(2014).

[43] Yang H Y, Liu R F, Xu Y X et al. Photosensitizer nanoparticles boost photodynamic therapy for pancreatic cancer treatment[J]. Nano-Micro Letters, 13, 35(2021).

[44] Li X S, Kwon N, Guo T et al. Innovative strategies for hypoxic-tumor photodynamic therapy[J]. Angewandte Chemie (International Ed. in English), 57, 11522-11531(2018).

[45] Xu Y X, Liu R F, Yang H Y et al. Enhancing photodynamic therapy efficacy against cancer metastasis by ultrasound-mediated oxygen microbubble destruction to boost tumor-targeted delivery of oxygen and renal-clearable photosensitizer micelles[J]. ACS Applied Materials & Interfaces, 14, 25197-25208(2022).

[46] Hong E J, Choi D G, Shim M S. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials[J]. Acta Pharmaceutica Sinica B, 6, 297-307(2016).

[47] Li X S, Lovell J F, Yoon J et al. Clinical development and potential of photothermal and photodynamic therapies for cancer[J]. Nature Reviews Clinical Oncology, 17, 657-674(2020).

[48] Mazière J C, Morlière P, Santus R. The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours[J]. Journal of Photochemistry and Photobiology B, 8, 351-360(1991).

[49] Luiza Andreazza N, Vevert-Bizet C, Bourg-Heckly G et al. Berberine as a photosensitizing agent for antitumoral photodynamic therapy: insights into its association to low density lipoproteins[J]. International Journal of Pharmaceutics, 510, 240-249(2016).

[50] Chen B L, Yan Y, Yang Y et al. A pyroptosis nanotuner for cancer therapy[J]. Nature Nanotechnology, 17, 788-798(2022).

[51] Paszko E, Ehrhardt C, Senge M O et al. Nanodrug applications in photodynamic therapy[J]. Photodiagnosis and Photodynamic Therapy, 8, 14-29(2011).

[52] Jung H S, Han J Y, Shi H et al. Overcoming the limits of hypoxia in photodynamic therapy: a carbonic anhydrase IX-targeted approach[J]. Journal of the American Chemical Society, 139, 7595-7602(2017).

[53] Yang Y X, Zhao X Z, Fan J L et al. Research progress on improving the tumor-targeting of photosensitizers in photodynamic therapy[J]. CIESC Journal, 72, 1-13(2021).

[54] Hu H, Wang H, Yang Y C et al. A bacteria-responsive porphyrin for adaptable photodynamic/photothermal therapy[J]. Angewandte Chemie (International Ed. in English), 61, e202200799(2022).

[55] Zhao Y Y, Zhang L, Chen Z X et al. Nanostructured phthalocyanine assemblies with efficient synergistic effect of type I photoreaction and photothermal action to overcome tumor hypoxia in photodynamic therapy[J]. Journal of the American Chemical Society, 143, 13980-13989(2021).

[56] Zheng B Z, Zhong D N, Xie T T et al. Near-infrared photosensitization via direct triplet energy transfer from lanthanide nanoparticles[J]. Chem, 7, 1615-1625(2021).

[57] Liu Y L, Zhao J, Xu X et al. Emodin-based nanoarchitectonics with giant two-photon absorption for enhanced photodynamic therapy[J]. Angewandte Chemie, 135, e202308019(2023).

[58] Karges J, Kuang S, Maschietto F et al. Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy[J]. Nature Communications, 11, 3262(2020).

[59] Wang S W, Lei M. Recent advances in two-photon excited photodynamic therapy[J]. Chinese Journal of Lasers, 49, 1507101(2022).

[60] Kleinovink J W, van Driel P B, Snoeks T J et al. Combination of photodynamic therapy and specific immunotherapy efficiently eradicates established tumors[J]. Clinical Cancer Research, 22, 1459-1468(2016).

[61] Rice S R, Li Y R, Busch T M et al. A novel prospective study assessing the combination of photodynamic therapy and proton radiation therapy: safety and outcomes when treating malignant pleural mesothelioma[J]. Photochemistry and Photobiology, 95, 411-418(2019).

[62] Pigula M, Huang H C, Mallidi S et al. Size-dependent tumor response to photodynamic therapy and irinotecan monotherapies revealed by longitudinal ultrasound monitoring in an orthotopic pancreatic cancer model[J]. Photochemistry and Photobiology, 95, 378-386(2019).

[63] Broekgaarden M, Rizvi I, Bulin A L et al. Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids[J]. Oncotarget, 9, 13009-13022(2018).

[64] Zhang M J, Weng Y H, Cao Z Y et al. ROS-activatable siRNA-engineered polyplex for NIR-triggered synergistic cancer treatment[J]. ACS Applied Materials & Interfaces, 12, 32289-32300(2020).

[65] Zhao R R, Liang X L, Zhao B et al. Ultrasound assisted gene and photodynamic synergistic therapy with multifunctional FOXA1-siRNA loaded porphyrin microbubbles for enhancing therapeutic efficacy for breast cancer[J]. Biomaterials, 173, 58-70(2018).

[66] Son S, Kim J H, Wang X W et al. Multifunctional sonosensitizers in sonodynamic cancer therapy[J]. Chemical Society Reviews, 49, 3244-3261(2020).

[67] Ouyang J, Tang Z M, Farokhzad N et al. Ultrasound mediated therapy: recent progress and challenges in nanoscience[J]. Nano Today, 35, 100949(2020).

[68] Yue W W, Chen L, Yu L D et al. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice[J]. Nature Communications, 10, 2025(2019).

[69] Zhu T C. Dosimetry in pleural photodynamic therapy[J]. Journal of the National Comprehensive Cancer Network: JNCCN, 10, S60-S64(2012).

[70] Li B H, Xie S S, Wilson B C. Advances in photodynamic therapy dosimetry[J]. Progress in Biochemistry and Biophysics, 36, 676-683(2009).